Top Markets
Coin of the day
Jinling Pharmaceutical Company Limited Jinling Pharmaceutical Company Limited

Jinling Pharmaceutical Company Limited

000919
Rang in Aktien #12250
Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in... Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in the manufacture and distribution of a diverse range of pharmaceutical products. Its key offerings include the Mailuoning injection, prescribed for the management of numerous vascular and thrombotic conditions such as thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and its sequelae, multiple forms of arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis. The company also provides ferrous succinate tablets for the prevention and treatment of iron deficiency anemia, alongside lentinan injection used in the therapy of malignant tumors. Furthermore, Jinling Pharmaceutical offers medical health care services. The firm's operations are primarily based in Nanjing, China.
Aktienkurs
$0.96947389
Marktkapitalisierung
$602.94M
Veränderung (1 Tag)
-2.34%
Veränderung (1 Jahr)
-2.77%
Land
CN
Handel Jinling Pharmaceutical Company Limited (000919)

Kategorie

EPS für Jinling Pharmaceutical Company Limited (000919)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Jinling Pharmaceutical Company Limited beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Jinling Pharmaceutical Company Limited von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber